Datum
November 29, 2024
Zeit
1:00 pm - 8:30 pm
Veranstaltungsort
Stadthaus Ulm
Dear colleagues and friends,
The successful series of joint events between the BioPharma Cluster South Germany and the German Society for Biochemistry and Molecular Biology (GBM) continues.
In 2024, we will focus on Virus based Therapies, highlighting and discussing the status, future opportunities and challenges of these novel promising therapeutic approaches, particularly in the light of the novel National Strategy for Gene and Cell Therapies.
The event will cover various aspects, ranging from market developments and the current research landscape of virus-based biopharmaceuticals to industrial-scale study cases for their production and clinical application – always with the patients’ view in mind!
It is aimed at researchers, developers and engineers from industry and academia, young scientists, physicians and anyone interested in this rapidly growing therapeutic field.
At the event, we will offer all participants the opportunity for a vivid exchange and networking with speakers and other experts.
We would be pleased to welcome you on November 29th at the “Stadthaus” in Ulm at the Münster Platz and look forward to an inspiring meeting with you!
Uwe Bücheler
(Senior Advisor Biopharmaceuticals, Boehringer Ingelheim; Chairman of the BioPharma Cluster South Germany)
Please click here to visit the events homepage.
Neueste Kommentare